Related references
Note: Only part of the references are listed.The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model
Jinjiao He et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
The structural basis of herpesvirus entry
Sarah A. Connolly et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier et al.
NATURE COMMUNICATIONS (2021)
Inhibition of glioma using a novel non-neurotoxic vesicular stomatitis virus
Bin Jiang et al.
NEUROSURGICAL FOCUS (2021)
Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas
Nidal B. Omar et al.
NEUROSURGICAL FOCUS (2021)
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
Assuntina G. Sacco et al.
LANCET ONCOLOGY (2021)
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
G. K. Friedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
Michael C. Brown et al.
NATURE COMMUNICATIONS (2021)
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
Miika Martikainen et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Hong-My Nguyen et al.
ONCOLYTIC VIROTHERAPY (2021)
Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1
Kyoung-Ju Kim et al.
GENE THERAPY (2021)
Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice
Joshua D. Bernstock et al.
CANCER GENE THERAPY (2020)
Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis
Zhe Zhu et al.
CELL STEM CELL (2020)
Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors
Xue Zhang et al.
JOURNAL OF VIROLOGY (2020)
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
Mubeen M. Mosaheb et al.
NATURE COMMUNICATIONS (2020)
Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells
Ivan Trus et al.
VIRUSES-BASEL (2020)
Delivery and Biosafety of Oncolytic Virotherapy
Lizhi Li et al.
FRONTIERS IN ONCOLOGY (2020)
Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
E. Antonio Chiocca et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
Noemi Garcia-Romero et al.
CELLS (2020)
Systematic Characterization of the Biodistribution of the Oncolytic Virus M1
Jing Cai et al.
HUMAN GENE THERAPY (2020)
Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor
Mayank Srivastava et al.
NATURE COMMUNICATIONS (2020)
Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells
Andrew T. Crane et al.
PLOS ONE (2020)
Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies
Christian Ronn Hansen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Oncolytic H-1 Parvovirus Enters Cancer Cells through Clathrin-Mediated Endocytosis
Tiago Ferreira et al.
VIRUSES-BASEL (2020)
Integrated Transcriptome and Histone Modification Analysis Reveals NDV Infection Under Heat Stress Affects Bursa Development and Proliferation in Susceptible Chicken Line
Ganrea Chanthavixay et al.
FRONTIERS IN GENETICS (2020)
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
M. R. Chambers et al.
FRONTIERS IN SURGERY (2020)
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade (vol 20, 380, 2020)
Seyed Mohammad Miri et al.
CANCER CELL INTERNATIONAL (2020)
Atezolizumab in patients with advanced non -small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Shirish M. Gadgeel et al.
LUNG CANCER (2019)
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
Lucio Crino et al.
LUNG CANCER (2019)
Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments
Gioacchin Iannolo et al.
CELL DEATH & DISEASE (2019)
Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models
Naiara Martinez-Velez et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
David W. Vredevoogd et al.
CELL (2019)
Caspases in Cell Death, Inflammation, and Disease
Nina Van Opdenbosch et al.
IMMUNITY (2019)
Akt in cancer: Mediator and more
Sundaramoorthy Revathidevi et al.
SEMINARS IN CANCER BIOLOGY (2019)
Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells
Daniel P. Strange et al.
MBIO (2019)
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martinez-Velez et al.
NATURE COMMUNICATIONS (2019)
Zika virus NS5 protein inhibits cell growth and invasion of glioma
Hongjian Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
EXTH-62. STEM CELL DELIVERY OF ONCOLYTIC ADENOVIRUS DNX-2401 FOLLOWING SURGICAL RESECTION FOR THE TREATMENT OF GLIOBLASTOMA
Sricharan Gopakumar et al.
NEURO-ONCOLOGY (2019)
ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL
Kevin Cassady et al.
NEURO-ONCOLOGY (2019)
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
Carmela Passaro et al.
CLINICAL CANCER RESEARCH (2019)
Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy
Andrea Gonzalez-Morales et al.
JOURNAL OF PROTEOMICS (2019)
Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus-1 G207 in Pediatric Malignant Supratentorial Brain Tumors
Joshua D. Bernstock et al.
WORLD NEUROSURGERY (2019)
PKR: A Kinase to Remember
Shunit Gal-Ben-Ari et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma
Srinath Rajaraman et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma
Hans-Georg Wirsching et al.
JCI INSIGHT (2019)
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma
Hiroshi Nakashima et al.
CLINICAL CANCER RESEARCH (2018)
Fighting Cancer with Viruses: Oncolytic Virus Therapy in China
Ding Wei et al.
HUMAN GENE THERAPY (2018)
Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma
Dipongkor Saha et al.
IMMUNOTHERAPY (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells
Ross W. Walton et al.
JOURNAL OF VIROLOGY (2018)
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells
Cole Peters et al.
JOURNAL OF VIROLOGY (2018)
Mechanisms of clathrin-mediated endocytosis
Marko Kaksonen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
Wouter B. L. van den Bossche et al.
NEURO-ONCOLOGY (2018)
Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells
Jonathan A. Lubin et al.
NEUROSURGERY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory
Mohammed G. Ghonime et al.
TRANSLATIONAL ONCOLOGY (2018)
DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report
Sonia Tejada et al.
FRONTIERS IN ONCOLOGY (2018)
PKR Senses Nuclear and Mitochondrial Signals by Interacting with Endogenous Double-Stranded RNAs
Yoosik Kim et al.
MOLECULAR CELL (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
Qi Chen et al.
MBIO (2018)
Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
Yang Bai et al.
SCIENTIFIC REPORTS (2018)
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
Gregory K. Friedman et al.
SCIENTIFIC REPORTS (2018)
Oncolytic virus immunotherapy: future prospects for oncology
Junaid Raja et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3
Zahid M. Delwar et al.
CANCER RESEARCH (2018)
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Yufang Shi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Zika virus has oncolytic activity against glioblastoma stem cells
Zhe Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis
Ling Shen et al.
JOURNAL OF VIROLOGY (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs
Michael C. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas
Minna Niittykoski et al.
TRANSLATIONAL ONCOLOGY (2017)
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
Assia L. Angelova et al.
VIRUSES-BASEL (2017)
Apoptosis-inducing effect of myxoma virus on human neuroglioma cell lines
Qiu-Sheng Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo
Junfen Ma et al.
ONCOLOGY LETTERS (2017)
MNK Controls mTORC1: Substrate Association through Regulation of TELO2 Binding with mTORC1
Michael C. Brown et al.
CELL REPORTS (2017)
Zika Virus Disease and Associated Neurologic Complications
Lindsey M. Duca et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
Julia V. Cockle et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity
Anne Kleijn et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain
Lukxmi Balathasan et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro
Bin Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas
Vidyalakshmi Chandramohan et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy
Silvia von Karstedt et al.
NATURE REVIEWS CANCER (2017)
Central nervous system gliomas
Michele Reni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+and CD15+cells are sensitive to killing by oncolytic herpes simplex viruses
Gregory K. Friedman et al.
NEURO-ONCOLOGY (2016)
Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth
Hengli Tang et al.
CELL STEM CELL (2016)
Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells
Tomasz J. Nowakowski et al.
CELL STEM CELL (2016)
Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer
Ellen Clarke et al.
IMMUNOTHERAPY (2016)
Epidemiology of Brain Tumors
Katharine A. McNeill
NEUROLOGIC CLINICS (2016)
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
Gila Kazimirsky et al.
STEM CELL RESEARCH & THERAPY (2016)
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
Daxa M. Patel et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2016)
A molecular arms race between host innate antiviral response and emerging human coronaviruses
Lok-Yin Roy Wong et al.
VIROLOGICA SINICA (2016)
479. Long Term Follow Up of Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpes Virus (Talimogene Laherparepvec, T-VEC) in Patients with Unresectable Metastatic Melanoma
MOLECULAR THERAPY (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Biology of Zika Virus Infection in Human Skin Cells
Rodolphe Hamel et al.
JOURNAL OF VIROLOGY (2015)
C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy
S. R. Klein et al.
ONCOGENE (2015)
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario
Cestmir Altaner et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Mitogen-Activated Protein Kinase-Interacting Kinase Regulates mTOR/AKT Signaling and Controls the Serine/Arginine-Rich Protein Kinase-Responsive Type 1 Internal Ribosome Entry Site-Mediated Translation and Viral Oncolysis
Michael C. Brown et al.
JOURNAL OF VIROLOGY (2014)
Induction of Viral, 7-Methyl-Guanosine Cap-Independent Translation and Oncolysis by Mitogen-Activated Protein Kinase-Interacting Kinase-Mediated Effects on the Serine/Arginine-Rich Protein Kinase
Michael C. Brown et al.
JOURNAL OF VIROLOGY (2014)
WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration
Wen Zhu et al.
MOLECULAR CANCER (2014)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
Frederick F. Lang et al.
NEURO-ONCOLOGY (2014)
Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
Hong Jiang et al.
PLOS ONE (2014)
Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment
Sebastian Vogel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury
Run Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Type I Interferons Induce Apoptosis by Balancing cFLIP and Caspase-8 Independent of Death Ligands
Amir Apelbaum et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumorbased orthotopic xenograft mouse models of pediatric glioma
Zhigang Liu et al.
NEURO-ONCOLOGY (2013)
Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
Chunchun Meng et al.
ARCHIVES OF VIROLOGY (2012)
Oncolytic Virus Therapy for Glioblastoma Multiforme Concepts and Candidates
Guido Wollmann et al.
CANCER JOURNAL (2012)
Attenuation of Neurovirulence, Biodistribution, and Shedding of a Poliovirus:Rhinovirus Chimera after Intrathalamic Inoculation in Macaca fascicularis
Elena Y. Dobrikova et al.
JOURNAL OF VIROLOGY (2012)
Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and Vstat120-expressing Oncolytic Virus
Ji Young Yoo et al.
MOLECULAR THERAPY (2012)
Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1
Irina Kiprianova et al.
CLINICAL CANCER RESEARCH (2011)
Cytoplasmic DNA innate immune pathways
Glen N. Barber
IMMUNOLOGICAL REVIEWS (2011)
Human Adenovirus Type 5 Induces Cell Lysis through Autophagy and Autophagy-Triggered Caspase Activity
Hong Jiang et al.
JOURNAL OF VIROLOGY (2011)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Sensing and Signaling in Antiviral Innate Immunity
Luke A. J. O'Neill et al.
CURRENT BIOLOGY (2010)
Bovine herpesvirus 4 based vector as a potential oncolytic-virus for treatment of glioma
Marco Redaelli et al.
VIROLOGY JOURNAL (2010)
Protein kinase R reveals an evolutionary model for defeating viral mimicry
Nels C. Elde et al.
NATURE (2009)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-β-dependent HIF-Iα-mediated induction of CXCL12
Ghazaleh Tabatabai et al.
BRAIN (2006)
Tumor selective replication of Newcastle Disease Virus: Association with defects of tumor cells in antiviral defence
Christoph Fiola et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas
XQ Lun et al.
CANCER RESEARCH (2005)
Viruses know it all: new insights into IFN networks
H Hengel et al.
TRENDS IN IMMUNOLOGY (2005)
Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection
KA Cassady
JOURNAL OF VIROLOGY (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
TNF-Related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus
B Washburn et al.
JOURNAL OF IMMUNOLOGY (2003)
Malignant glioma: genetics and biology of a grave matter
EA Maher et al.
GENES & DEVELOPMENT (2001)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Share Paper
